Care segment guides

Buying or selling hospice agencies

Hospice agencies provide care and support for eligible terminally ill patients and their families, with business performance tied to clinical obligations and payment integrity. A sale requires more than comparing census and revenue. Review sustainable earnings, cap exposure, staffing, ownership history and the transition plan together while protecting patient choice, privacy and continuity of care.

Rules current as of September 2026 — verify with the licensing agency. This educational review is limited to the issues and sources identified below.

Book a confidential intro call

Jason Taken · HedgeStone Business Advisors

Jump to a section

Key takeaways

  • Patient-day revenue must be evaluated with eligibility, care costs, collections and potential payment adjustments.
  • Aggregate cap obligations and unresolved reviews need their own evidence and treatment in the transaction.
  • The hospice majority-ownership rule and current enrollment moratorium deserve review before a closing assumption.
  • A qualified buyer needs clinical and operational capacity as well as purchase financing.

Begin with the care model and the people it serves

A hospice acquisition transfers responsibility for a service business supporting patients and families during a vulnerable time. The commercial plan must fit the care model. Growth, staffing and cost decisions cannot be evaluated solely through their effect on a purchase-price calculation.

CMS describes hospice as comprehensive care and support for terminally ill patients and families. Medicare benefit eligibility includes certification and patient election, with care organized around an individualized plan. The agency must provide or arrange the applicable services, rather than treating a daily payment as payment for only the visits completed that day. (Source: CMS hospice coverage)

Identify the actual operation being sold: the legal entity, service footprint, licensed locations, payer participation, contracts and any inpatient component. Determine whether a related home health or personal-care business is included. Separate each service line before comparing margins or assigning value.

The home health overview and home care overview help distinguish adjacent models. Shared ownership, an office or a referral relationship does not make their payment and regulatory requirements interchangeable.

Understand patient-day revenue without reducing care to a metric

Average daily census and patient days help describe activity, but they are starting points. Review admissions, discharges, length-of-stay distribution, care levels, billed amounts, adjustments, refunds and cash receipts. Use consistent periods and document changes in reporting definitions.

Medicare generally pays hospice a daily amount based on one of four levels of care: routine home care, continuous home care, inpatient respite and general inpatient care. The applicable level depends on care circumstances and requirements. It is not a discretionary choice to improve the agency's margin. (Source: CMS hospice levels of care)

Connect revenue with the costs of nursing, other clinical and supportive services, medications, equipment, supplies and administration. Determine what is employed, contracted or shared. A strong collection month does not show the recurring cost of meeting all care obligations.

Read length-of-stay information carefully

An average can conceal very different patient populations and operating patterns. Ask qualified reviewers to interpret distributions and selected records, including the basis for eligibility and recertification. A long stay alone does not establish improper billing; a short stay alone does not prove sound documentation.

Do not forecast improvements by assuming the business can alter a patient's stay to fit a financial target. Patient circumstances, choice and clinical requirements govern care decisions. The acquisition model should estimate resources for appropriate services and distinguish confirmed performance from speculative changes.

Reconcile earnings before discussing a multiple

Request monthly financial statements, tax returns, the general ledger, patient activity, claims, remittances, bank reconciliations and receivable aging. Explain differences among revenue recognized, amounts billed and cash collected. Separate prior-period recoveries or refunds from current operating trends.

Normalize earnings using documented adjustments. If an owner is also responsible for administration, referral coordination or another essential function, include a credible replacement cost. A buyer cannot assume a departing person's work vanishes with their compensation.

Review temporary expenses and unusual receipts with equal skepticism. One-time revenue should not support recurring debt service, and a necessary recurring expense should not be removed merely because the seller hopes the buyer will perform the task more cheaply.

Earnings issueSupporting recordsUseful question
Patient-day activityAdmissions, discharges, care-level reportsWhat changed in the service population?
Payment realizationClaims, remittances, denials and refundsHow much reported revenue became cash?
Care delivery costPayroll, contractors, pharmacy and equipment invoicesWhat resources supported the care provided?
Owner dependenceDuties, time commitments and replacement planWhat work must the buyer fund?
Cap and review exposureCalculations, notices, determinations and repaymentsWhat may change historical or future cash?
ContinuityStaff and vendor terms, systems and approvalsCan the operation sustain performance after transfer?

The senior care valuation guide provides the broader framework. No universal hospice multiple is established here. A credible valuation must reflect the target's evidence and the terms of the actual transaction, including its liabilities and funding needs.

Treat aggregate cap exposure as a separate workstream

Hospice cap analysis should not be buried inside one unexplained earnings adjustment. Request historical self-determined filings, supporting data, contractor determinations, repayment evidence, appeals and current estimates. Label which periods and amounts are final and which can still change.

Federal regulation limits total Medicare hospice payments through the applicable aggregate cap framework. It requires a cap determination filing within five months after cap-year end using data no earlier than three months after the period, with overpayments due and refundable excess payments. (Source: 42 CFR 418.308)

A reimbursement specialist should evaluate the historical periods and the period spanning closing. The buyer and seller then need a legal allocation that addresses later determinations, records access, cooperation and payment. Do not assume that a simple pro rata division by days produces the right transaction result.

Distinguish aggregate cap exposure from other payment limitations and review findings. Each can have different evidence and settlement mechanics. Avoid a generic reserve percentage without a supported calculation and an explanation of what it covers.

Review the cost and resilience of the care team

Map clinical leadership, nursing, medical director arrangements, social work, counseling, aides and administrative functions as applicable. Identify the actual people performing the work, their qualifications, schedules, employment status and backup coverage. Review vacancies and dependence on temporary or contracted staff.

Ask how the agency handles urgent needs, absences, difficult coverage periods and coordination with outside facilities. An organization chart can appear complete while practical capacity remains fragile. Use operational evidence to understand how care is delivered outside ordinary office hours.

Examine medication, equipment and supply arrangements and any inpatient service contracts. Confirm what continues after transfer and on what terms. Review outstanding balances, service issues and proposed changes before assuming the buyer can immediately replace vendors without disruption.

Price the actual transition plan. Retaining key staff, recruiting replacements, training a new team and maintaining backup support may create one-time and recurring costs. Separate them in the forecast so the seller's earnings and the buyer's funding need are both presented accurately.

Examine referral relationships with appropriate care

Measure referral concentration consistently by source, period and outcome. Inquiries, admissions and collected revenue answer different questions. Review shifts over time and identify dependence on relationships managed personally by the departing owner.

Consider how the organization communicates with referring providers, facilities, patients and families. An introduction plan can be useful, but no buyer should treat future patient choices or referral volume as guaranteed assets. Review relevant arrangements with healthcare counsel.

OIG's General Compliance Program Guidance offers a voluntary framework for examining oversight, reporting channels and responses to concerns. Use it to ask how practices are supervised and corrected. A signed policy does not establish that every arrangement or activity is compliant. (Source: OIG General Compliance Program Guidance)

Growth assumptions deserve the same evidence standard as historical results. A larger service area, another salesperson or a new facility relationship does not by itself prove future admissions, staffing capacity or profitability.

Keep survey, medical-review and program status distinct

Collect survey findings, complaint records, corrective actions, medical-review requests, denials, appeals and other relevant oversight correspondence. Track each matter to its latest status. A response submitted by the agency is different from a documented final resolution.

CMS states that implementation of its Hospice Special Focus Program for calendar year 2025 ceased on February 14, 2025. This specific statement should not be broadened into a claim that hospice oversight ended. (Source: CMS Hospice Special Focus Program)

Separate CMS materials address medical review and other hospice oversight mechanisms. Verify which processes apply to the target and request the underlying correspondence. Neither a general policy announcement nor the absence of an item in public search proves that an agency has no open issues. (Source: CMS hospice medical review and oversight)

The hospice diligence guide explains how to connect these findings with clinical review, financial exposure and transaction decisions.

Verify ownership history before choosing a closing structure

Collect the effective date of initial Medicare enrollment, subsequent majority-ownership changes, current ownership interests and proposed buyer structure. Compare those facts with the purchase documents. The age of the business name does not establish the relevant enrollment chronology.

Current 42 CFR 424.550 includes hospice in its majority-ownership rule. A covered change within the relevant 36-month period can require new enrollment and a survey or approved accreditation unless an enumerated exception applies. The rule can include asset sales, stock transfers, mergers and consolidations. (Source: 42 CFR 424.550)

Document any proposed exception rather than relying on an informal description. Counsel and enrollment specialists should coordinate with the Medicare Administrative Contractor on the actual facts. A purchase agreement cannot grant Medicare billing authority or make a provider number freely transferable.

State licenses, payer contracts, leases and other consents require separate attention. Keep an approval matrix that distinguishes required notices, applications, consents and final confirmations. The deal should have a coherent operating pathway before the buyer assumes revenue continues on the closing date.

Include the current HHA and hospice moratorium in feasibility review

CMS implemented a nationwide enrollment moratorium for home health agencies and hospices effective May 13, 2026. Its affected applications include initial enrollment and non-exempt majority-ownership changes. The scope matters when the proposed hospice acquisition would otherwise require a new initial enrollment. (Source: CMS provider enrollment moratoria)

The moratorium does not mean every transaction involving an existing hospice is prohibited. It also does not mean a buyer can solve an affected application merely by switching the purchase agreement from assets to stock. Have the actual structure assessed before treating financing or a target close as dependable.

CMS explains that moratoria operate for six-month periods and may be extended. Avoid assuming an automatic end date or a discretionary exception for the parties. The moratorium guide and 36-month rule guide explain the separate questions. (Source: CMS moratorium FAQs)

Prepare the seller's records and disclosure plan

Organize a sale package with clear periods, reconciled figures and known limitations. Include ownership history, financials, payer and vendor agreements, staffing duties, cap records and open-review correspondence. A buyer should be able to distinguish verified performance from estimates and management expectations.

Use a blind teaser for appropriate early marketing and qualify buyers before releasing sensitive information. Even anonymous details can identify an agency when combined, so review service geography and distinctive facts carefully.

Patient-level information requires a legally supported access process. HHS minimum-necessary guidance applies to relevant uses and disclosures, and an NDA alone does not resolve privacy obligations. Arrange necessary clinical review through qualified reviewers and appropriate safeguards. (Source: HHS minimum necessary)

Plan required notices and communication alongside confidentiality. Patients and families deserve accurate information at the appropriate time. Avoid assurances about continued personnel, services or arrangements unless the buyer has committed and prepared to support them.

Match buyer capability and financing to the actual operation

A prospective buyer needs enough capital to acquire the business and sustain care after closing. Assess the buyer's management plan, clinical leadership, staffing resources, reimbursement support and ability to respond to identified issues. Financial interest alone does not establish operating readiness.

Build a complete transaction budget: price, fees, lender expenses, necessary systems work, vendor deposits, recruiting, retention arrangements and operating cash. Include potential repayment or settlement exposure according to the negotiated structure and professional advice. Do not count the same reserve as available working capital twice.

SBA 7(a) can finance eligible business acquisitions under program and lender requirements, but eligibility and approval are specific to the borrower and deal. A lender needs a realistic operating and authorization plan, not just a revenue total. (Source: SBA 7(a))

Use the working-capital guide to model cash timing and receivable treatment. Stress-test delayed receipts while preserving funding for payroll, medication, equipment and other necessary services.

Connect the purchase terms to day-one responsibility

Resolve who handles historical claims, cap settlements, refunds, records requests and open reviews. Define information access and cooperation after closing. Counsel should assess contractual allocation, recourse and any negotiated escrow; those terms do not necessarily control what third parties can pursue.

Write a transition responsibility list covering clinical leadership, on-call arrangements, pharmacy and equipment vendors, payroll, billing, records, staff communication and patient or family questions. Test whether the people named have agreed to their roles and will have the necessary access and resources.

Refresh diligence before closing if material facts change. New payer correspondence, a key departure or a collection problem may alter a previously reasonable assumption. A clear process for updates helps the parties address evidence without reopening every settled commercial point.

The first 90 days guide helps organize the next stage. Preserve care continuity first, compare results with the acquisition assumptions, and make supported operational changes. A successful handoff requires the financial, clinical and legal plans to describe the same functioning business.

Frequently asked questions

How is a hospice agency different from a home health agency?

Hospice focuses on care and support for eligible terminally ill patients and families under the applicable hospice benefit and care plan. Home health has a different clinical and payment framework. Their financial metrics, documentation, staffing needs and diligence questions should be analyzed separately.

What determines the value of a hospice agency?

Supported earnings, care capacity, payment integrity, cap exposure, referral dependence, leadership continuity and transfer feasibility all matter. Patient count or revenue alone does not establish value. Use reconciled records and qualified reviews before selecting valuation assumptions.

Is average daily census enough to assess a hospice business?

No. It describes activity but does not establish eligibility, appropriate care, collectible revenue, cost or cap exposure. Reconcile patient days to claims and cash, review trends and obtain clinical and reimbursement assessment where needed.

Can a hospice patient remain eligible beyond six months?

CMS describes two initial 90-day periods followed by subsequent 60-day periods with applicable recertification requirements. Continued eligibility depends on the patient's circumstances and supporting clinical certification. A business model should not treat a six-month prognosis as an automatic maximum stay or a revenue target.

Does the 36-month majority-ownership rule include hospice?

Yes. Current 42 CFR 424.550 includes hospice and home health. Review initial enrollment, the latest majority-ownership change, the transaction form and any documented exception. The current enrollment moratorium adds a separate question when initial enrollment would be required.

Did the end of the 2025 Hospice Special Focus Program end oversight?

No. CMS states that CY2025 Special Focus Program implementation ceased on February 14, 2025. Separate survey, medical review, payment and other oversight requirements must still be assessed. The status of one program does not establish the target hospice's compliance or review status.

How should a sale address aggregate cap exposure?

Collect calculations, filings, determinations, repayments and current estimates by cap period. Have reimbursement specialists and counsel define identified and contingent exposure and address records access, settlement responsibility and any negotiated reserve. Do not assume an accounting entry settles the obligation.

What should the buyer prioritize immediately after closing?

Maintain qualified care leadership, staffing, medication and equipment arrangements, records access, payroll and billing processes. Follow the agreed communication and notice plan. Track collections and unresolved review matters while testing the assumptions used to finance and value the acquisition.

Sources

Sources are dated to distinguish current guidance from earlier publications. They support the identified facts; the transaction questions and examples are educational analysis.

  1. CMS: hospice payment (2026). Retrieved September 5, 2026.
  2. eCFR: 42 CFR 418.308 hospice payment limitation (2026). Retrieved September 5, 2026.
  3. eCFR: 42 CFR 418.302 hospice payment procedures (2026). Retrieved September 5, 2026.
  4. eCFR: 42 CFR 424.550 (2026). Retrieved September 5, 2026.
  5. CMS: provider enrollment moratoria (2026). Retrieved September 5, 2026.
  6. CMS: home health and hospice moratorium FAQs (2026). Retrieved September 5, 2026.
  7. CMS: Hospice Special Focus Program (2025). Retrieved September 5, 2026.
  8. CMS: hospice medical review and oversight (2026). Retrieved September 5, 2026.
  9. HHS: minimum necessary requirement (2003). Retrieved September 5, 2026.
  10. HHS OIG: General Compliance Program Guidance (2023). Retrieved September 5, 2026.
  11. SBA: 7(a) loans (2026). Retrieved September 5, 2026.
Jason Taken

Business broker · HedgeStone Business Advisors
jason.taken@hedgestone.com

AI-assisted educational content. Research methods and editorial standards. Published September 5, 2026.

A conversation, at your pace

Make an informed next move.

Talk with Jason Taken about your business, your plans, and the issues to resolve before a transaction.

Schedule your introduction with Jason